OmniAb (OABI) Assets Average (2021 - 2026)
OmniAb (OABI) reported Assets Average of $297.3 million for Q1 2026, down 5.88% year-over-year from $315.9 million in Q1 2025, and down 2.63% quarter-over-quarter from $305.3 million in Q4 2025.
OmniAb (OABI) Assets Average (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Assets Average data on file, last reported at $297.3 million in Q1 2026.
- Assets Average for Q1 2026 came in at $297.3 million, down 5.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $297.3 million (down 5.88% YoY), and the FY2025 annual result was $313.2 million, down 10.6% from the prior year.
- Assets Average declined to $297.3 million in Q1 2026 per OABI's latest filing, from $305.3 million in the prior quarter.
- Over five years, Assets Average peaked at $417.1 million in Q1 2023 and troughed at $236.8 million in Q2 2022.
- A 5-year average of $328.0 million and a median of $328.6 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2024: Assets Average surged 99.64% in 2022, then declined 16.08% in 2024.
- A 5-year view of Assets Average shows it stood at $329.4 million in 2022, then rose by 16.41% to $383.5 million in 2023, then slipped by 14.32% to $328.6 million in 2024, then fell by 7.08% to $305.3 million in 2025, then slipped by 2.63% to $297.3 million in 2026.
- Business Quant data shows OABI's Assets Average at $297.3 million in Q1 2026, $305.3 million in Q4 2025, and $302.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 297.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 297.28 Mn |
| Dec 31, 2025 | 305.30 Mn |
| Sep 30, 2025 | 302.68 Mn |
| Jun 30, 2025 | 300.93 Mn |
| Mar 31, 2025 | 315.87 Mn |
| Dec 31, 2024 | 328.56 Mn |
| Sep 30, 2024 | 334.41 Mn |
| Jun 30, 2024 | 344.91 Mn |
| Mar 31, 2024 | 363.89 Mn |
| Dec 31, 2023 | 383.47 Mn |
| Sep 30, 2023 | 398.47 Mn |
| Jun 30, 2023 | 409.14 Mn |
| Mar 31, 2023 | 417.13 Mn |
| Dec 31, 2022 | 329.41 Mn |
| Sep 30, 2022 | 237.20 Mn |
| Jun 30, 2022 | 236.85 Mn |
| Mar 31, 2022 | 270.68 Mn |
| Dec 31, 2021 | 270.73 Mn |
| Sep 30, 2021 | 118.81 Mn |